Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
15.22
+0.24 (1.60%)
At close: Jun 9, 2026, 4:00 PM EDT
15.20
-0.02 (-0.13%)
Pre-market: Jun 10, 2026, 5:43 AM EDT

Jade Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9039561,511628724288
Market Cap Growth
298.67%-36.76%140.56%-13.27%151.70%-
Enterprise Value
593.01708.711,619506.09595.87120.81
Last Close Price
15.2215.4392.75792.051025.50412.65
PB Ratio
2.537295.48-5.745.721.67
P/TBV Ratio
-2011.983693.77-5.445.660.84
Debt / Equity Ratio
-2.005.5353800.000.000.010.00
Net Debt / Equity Ratio
751.56-1885.47--1.11-1.01-0.97
Net Debt / EBITDA Ratio
1.912.18-1.451.502.417.25
Net Debt / FCF Ratio
2.192.60-1.512.143.266.05
Quick Ratio
11.4914.9806.9416.6165.64
Current Ratio
11.4921.095.817.0416.9068.37
Return on Equity (ROE)
124028.00%-191594.00%-127.22%-63.95%-34.44%-26.19%
Return on Assets (ROA)
-39.91%-53.71%-74.57%-62.02%-34.29%-25.57%
Return on Invested Capital (ROIC)
-176.41%-153.99%-228.00%-2090.03%-1084.78%-812.31%
Return on Capital Employed (ROCE)
-42.39%-57.63%-87.46%-68.61%-35.45%-26.20%
Buyback Yield / Dilution
--3740.15%-8.55%-7.60%-99.06%-4975.16%
Total Shareholder Return
--3740.15%-8.55%-7.60%-99.06%-4975.16%
SEC Filings: 10-K · 10-Q